Approval · Notice of Compliance 10673 · 2009
ORBAX: Notice of Compliance 10673
Issued October 16, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10673
- Date
- October 16, 2009
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in Ownership
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- ORBIFLOXACIN 5.7 MG per TAB
- ORBIFLOXACIN 22.7 MG per TAB
- ORBIFLOXACIN 68 MG per TAB